GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹8,799 Cr | ₹7,870 Cr | ₹9,457 Cr | ₹9,211 Cr | ₹7,234 Cr |
What is the latest Profit & Loss Account Balance ratio of GLENMARK PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹8,799 Cr |
| Mar2024 | ₹7,870 Cr |
| Mar2023 | ₹9,457 Cr |
| Mar2022 | ₹9,211 Cr |
| Mar2021 | ₹7,234 Cr |
How is Profit & Loss Account Balance of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,799 Cr | 11.79 | |
| Mar2024 | ₹7,870 Cr | -16.78 | |
| Mar2023 | ₹9,457 Cr | 2.67 | |
| Mar2022 | ₹9,211 Cr | 27.33 | |
| Mar2021 | ₹7,234 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,405.1 Cr | 0.5% | 6.4% | 27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.5% |
6.4% |
27.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses